Presentation TCT 2021 Debate: Follow the Ischemic Risk, Prolong DAPT! Presenter: Robert Yeh November 05, 2021
Presentation TCT 2021 Case Presentation: A Patient at High Ischemic and Bleeding Risks Presenter: Angelo Quagliana November 05, 2021
Presentation TCT 2021 Bleeding Risk Prediction and Stratification After PCI: The State of the Art in 2021 Presenter: Sunil Rao November 05, 2021
Presentation TCT 2021 Ischemic Risk Prediction and Stratification After PCI: The State of the Art in 2021 Presenter: Gennaro Giustino November 05, 2021
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
Presentation TCT 2021 Case #2: Antiplatelet Therapy Disruption Challenges After Stenting Presenter: George Dangas November 05, 2021
Presentation TCT 2021 Case #1: Bleeding and Ischemic Complications from the EXCEL Trial Presenter: Gregg Stone November 05, 2021
Presentation TCT 2021 Finding the Sweet Spot: Balancing Reducing Ischemic Risk and Reducing Bleeding Risk with Antiplatelet Therapy Presenter: Deepak Bhatt November 05, 2021
Presentation TCT 2021 Antiplatelet Therapy for Patients with Diabetes Undergoing PCI Presenter: Deepak Bhatt November 05, 2021
News Conference News TCT 2021 PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term Todd Neale November 05, 2021
Presentation TCT 2021 MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk Presenter: Pieter Smits November 05, 2021
News Conference News TCT 2021 More Complications With Plug Closure After TAVI: CHOICE-CLOSURE Michael O'Riordan November 05, 2021
News Conference News TCT 2021 ‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients Yael L. Maxwell November 04, 2021
News Conference News TCT 2021 FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD Michael O'Riordan November 04, 2021
News Daily News Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD L.A. McKeown November 04, 2021
News Daily News Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR Yael L. Maxwell November 03, 2021
News Conference News TCT 2021 FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results Todd Neale November 03, 2021